PhilipSchulmanMD

Oncology • Smithtown, NY

Chief, Medical Oncology MSKCC- Commack

Join to view full profile

Dr. Schulman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Schulman's full profile

Already have an account?

Office
48 Route 25A
Suite 209
Smithtown, NY 11787
Phone+1 631-751-3000
Is this information wrong?

Education & Training

Zucker School of Medicine at Hofstra/NorthwellFellowship, Hematology and Medical Oncology, 1978 - 1979
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1977 - 1978
Zucker School of Medicine at Hofstra/NorthwellResidency, Internal Medicine, 1975 - 1977
Zucker School of Medicine at Hofstra/NorthwellInternship, Internal Medicine, 1974 - 1975
SUNY Upstate Medical UniversityClass of 1974

Certifications & Licensure

NY State Medical License 1975 - 2025
PA State Medical License 2022 - 2024
FL State Medical License 2021 - 2023
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

13 citations
Bortezomib, liposomal doxorubicin and dexamethasone followed by thalidomide and dexamethasone is an effective treatment for patients with newly diagnosed multiple myel...
Heather Landau, Neeta Pandit-Taskar, Hani Hassoun, Adam D. Cohen, Alex Lesokhin, Nikoletta Lendvai, Pamela Drullinsky, Philip Schulman, Suresh C. Jhanwar, Elizabeth Ho...> ;Leukemia & Lymphoma. 2012 Feb 1
18 citations
Phase I Trial of Weekly and Twice-Weekly Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Relapsed or Refractory Non–Hodgkin Lymphoma
John F. Gerecitano, Carol S. Portlock, Paul A. Hamlin, Craig H. Moskowitz, Ariela Noy, David J. Straus, Philip Schulman, Otilia Dumitrescu, Debra M. Sarasohn, Jennifer...> ;Clinical Cancer Research. 2011 Apr 15
A phase I study evaluating two dosing schedules of bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P) in patients with relapsed/refractory in...
Gerecitano JF, Portlock C, Hamlin P, Moskowitz C, Noy A, Straus DJ, Zelenetz AD, Schulman P, Dumitrescu O, O'Connor OA> ;J. Clin. Oncol.. 2008-05-20

Hospital Affiliations

Memorial Sloan Kettering Cancer CenterNew York, New York
The Mount Sinai HospitalNew York, New York
Huntington HospitalHuntington, New York
Reading HospitalReading, Pennsylvania
Wyckoff Heights Medical CenterBrooklyn, New York